I'm aware of the GHDX move on last night's earnings. I sold out of GHDX on the last big move. I still think Biocartis is the better way to play TailorX uptake. They will sell more cartidges and consoles and other services.
I would not be surprised if Biocartis announces their intent to IPO in the U.S. at next weeks conference call. It's probably a little early since the market cap is only $650M and they are a year or two from profitability but it would be a good move to capitalize on the recent GH and GHDX moves.
Market Data 
Markets 
AI
